ASCO 2026: Highlights and analysis
1 Jun 2026
ASCO 2026: Highlights and analysis
The notions and needs for global oncology and implementing evidence to increase the affordability of better value cancer care worldwide, through science
ESMO 2025: Highlights and analysis
ASCO 2025: Highlights and analysis
A checklist for designing and reporting cancer drug phase 3 clinical trials
ESMO 2024: Highlights and analysis
Defining geriatric oncology
Revolving door between the regulators and industry
ASCO 2024: Highlights and analysis
The human inside oncology
Conflicts of interest in oncology
Patient benefit vs industry benefit finding a balance